1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. Fact.MR Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Market Opportunity Analysis
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
4. Global Economic Outlook
4.1. Global Healthcare Spending Outlook, by Region
5. Market Background
5.1. Market Dynamics
5.1.1. Drivers
5.1.2. Restraints
5.1.3. Trends
6. Key Inclusions
6.1. Key Competitors
6.2. Regulatory Scenario
6.3. Supply Chain Analysis
6.4. Value Chain Analysis
7. Global Market Analysis and Forecast
7.1. Global Market Outlook
7.1.1. Market Value Forecast and Analysis
7.2. Global Market Analysis by Product Type
7.2.1. Syrups & Drops
7.2.2. Tablets & Capsules
7.2.3. Powders, Pellets and Drink Mixes
7.2.4. Inhalers, Sprays and Rubs
7.2.5. Lozenge
7.3. Global Market Analysis by Distribution Channel
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Mail Order Pharmacies
7.3.4. E-Commerce
8. North America Market Analysis
8.1. Introduction
8.2. North America Market Outlook
8.2.1. Market Value (US$ Mn) Forecast and Analysis
8.2.2. Country Wise Demand Assessment
8.2.2.1. US Market Value & Volume Share
8.2.2.2. Canada Market Value & Volume Share
8.3. North America Market Analysis by Product Type
8.3.1. Value (US$ Mn) and Forecast by Product Type
8.3.2. Y-o-Y Growth Comparison by Product Type
8.4. North America Market Analysis by Distribution Channel
8.4.1. Value (US$ Mn) and Forecast by Distribution Channel
8.4.2. Y-o-Y Growth Comparison by Distribution Channel
8.5. Market Attractiveness Analysis
8.6. Impact Assessment of Market Forces
9. Latin America Market Analysis
9.1. Introduction
9.2. Latin America Market Outlook
9.2.1. Market Value (US$ Mn) Forecast and Analysis
9.2.2. Country Wise Demand Assessment
9.2.2.1. US Market Value & Volume Share
9.2.2.2. Canada Market Value & Volume Share
9.3. Latin America Market Analysis by Product Type
9.3.1. Value (US$ Mn) and Forecast by Product Type
9.3.2. Y-o-Y Growth Comparison by Product Type
9.4. Latin America Market Analysis by Distribution Channel
9.4.1. Value (US$ Mn) and Forecast by Distribution Channel
9.4.2. Y-o-Y Growth Comparison by Distribution Channel
9.5. Market Attractiveness Analysis
9.6. Impact Assessment of Market Forces
10. Western Europe Market Analysis
10.1. Introduction
10.2. Western Europe Market Outlook
10.2.1. Market Value (US$ Mn) Forecast and Analysis
10.2.2. Country Wise Demand Assessment
10.2.2.1. US Market Value & Volume Share
10.2.2.2. Canada Market Value & Volume Share
10.3. Western Europe Market Analysis by Product Type
10.3.1. Value (US$ Mn) and Forecast by Product Type
10.3.2. Y-o-Y Growth Comparison by Product Type
10.4. Western Europe Market Analysis by Distribution Channel
10.4.1. Value (US$ Mn) and Forecast by Distribution Channel
10.4.2. Y-o-Y Growth Comparison by Distribution Channel
10.5. Market Attractiveness Analysis
10.6. Impact Assessment of Market Forces
11. Eastern Europe Market Analysis
11.1. Introduction
11.2. Eastern Europe Market Outlook
11.2.1. Market Value (US$ Mn) Forecast and Analysis
11.2.2. Country Wise Demand Assessment
11.2.2.1. US Market Value & Volume Share
11.2.2.2. Canada Market Value & Volume Share
11.3. Eastern Europe Market Analysis by Product Type
11.3.1. Value (US$ Mn) and Forecast by Product Type
11.3.2. Y-o-Y Growth Comparison by Product Type
11.4. Eastern Europe Market Analysis by Distribution Channel
11.4.1. Value (US$ Mn) and Forecast by Distribution Channel
11.4.2. Y-o-Y Growth Comparison by Distribution Channel
11.5. Market Attractiveness Analysis
11.6. Impact Assessment of Market Forces
12. APEJ Market Analysis
12.1. Introduction
12.2. APEJ Market Outlook
12.2.1. Market Value (US$ Mn) Forecast and Analysis
12.2.2. Country Wise Demand Assessment
12.2.2.1. US Market Value & Volume Share
12.2.2.2. Canada Market Value & Volume Share
12.3. APEJ Market Analysis by Product Type
12.3.1. Value (US$ Mn) and Forecast by Product Type
12.3.2. Y-o-Y Growth Comparison by Product Type
12.4. APEJ Market Analysis by Distribution Channel
12.4.1. Value (US$ Mn) and Forecast by Distribution Channel
12.4.2. Y-o-Y Growth Comparison by Distribution Channel
12.5. Market Attractiveness Analysis
12.6. Impact Assessment of Market Forces
13. Japan Market Analysis
13.1. Introduction
13.2. Japan Market Outlook
13.2.1. Market Value (US$ Mn) Forecast and Analysis
13.2.2. Country Wise Demand Assessment
13.2.2.1. US Market Value & Volume Share
13.2.2.2. Canada Market Value & Volume Share
13.3. Japan Market Analysis by Product Type
13.3.1. Value (US$ Mn) and Forecast by Product Type
13.3.2. Y-o-Y Growth Comparison by Product Type
13.4. Japan Market Analysis by Distribution Channel
13.4.1. Value (US$ Mn) and Forecast by Distribution Channel
13.4.2. Y-o-Y Growth Comparison by Distribution Channel
13.5. Market Attractiveness Analysis
13.6. Impact Assessment of Market Forces
14. MEA Market Analysis
14.1. Introduction
14.2. MEA Market Outlook
14.2.1. Market Value (US$ Mn) Forecast and Analysis
14.2.2. Country Wise Demand Assessment
14.2.2.1. US Market Value & Volume Share
14.2.2.2. Canada Market Value & Volume Share
14.3. MEA Market Analysis by Product Type
14.3.1. Value (US$ Mn) and Forecast by Product Type
14.3.2. Y-o-Y Growth Comparison by Product Type
14.4. MEA Market Analysis by Distribution Channel
14.4.1. Value (US$ Mn) and Forecast by Distribution Channel
14.4.2. Y-o-Y Growth Comparison by Distribution Channel
14.5. Market Attractiveness Analysis
14.6. Impact Assessment of Market Forces
15. Forecast Factors: Relevance and Impact
16. Forecast Assumptions
17. Competition Analysis
17.1. Competition Dashboard
17.2. Competitors Deep Dive
17.2.1. Boiron Group
17.2.1.1. Overview
17.2.1.2. Product Portfolio
17.2.1.3. Financial Overview
17.2.1.4. Analyst Commentary
17.2.2. Blackmores Limited
17.2.2.1. Overview
17.2.2.2. Product Portfolio
17.2.2.3. Financial Overview
17.2.2.4. Analyst Commentary
17.2.3. Johnson & Johnson
17.2.3.1. Overview
17.2.3.2. Product Portfolio
17.2.3.3. Financial Overview
17.2.3.4. Analyst Commentary
17.2.4. Emami Ltd. (Zandu Pharmaceutical Works Ltd)
17.2.4.1. Overview
17.2.4.2. Product Portfolio
17.2.4.3. Financial Overview
17.2.4.4. Analyst Commentary
17.2.5. Dabur India Limited
17.2.5.1. Overview
17.2.5.2. Product Portfolio
17.2.5.3. Financial Overview
17.2.5.4. Analyst Commentary
17.2.6. Procter and Gamble
17.2.6.1. Overview
17.2.6.2. Product Portfolio
17.2.6.3. Financial Overview
17.2.6.4. Analyst Commentary
17.2.7. Tsumura & Co
17.2.7.1. Overview
17.2.7.2. Product Portfolio
17.2.7.3. Financial Overview
17.2.7.4. Analyst Commentary
17.2.8. Himalaya Global Holdings Ltd.
17.2.8.1. Overview
17.2.8.2. Product Portfolio
17.2.8.3. Financial Overview
17.2.8.4. Analyst Commentary
17.2.9. Hyland’s
17.2.9.1. Overview
17.2.9.2. Product Portfolio
17.2.9.3. Financial Overview
17.2.9.4. Analyst Commentary
17.2.10. Schwabe Group
17.2.10.1. Overview
17.2.10.2. Product Portfolio
17.2.10.3. Financial Overview
17.2.10.4. Analyst Commentary
18. Assumptions and Acronyms Used
19. Research Methodology